Clonal hematopoiesis: A challenge or opportunity in liquid biopsy?

Clonal Hematopoiesis (CH) involves the presence of specific blood cell clones that have acquired mutations, often linked to ageing, detectable in the blood without necessarily indicating disease. In the realm of liquid biopsy—particularly for cancer diagnosis, treatment monitoring, and risk assessment—CH offers both challenges and valuable insights.